Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadzic, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadzic, N
Arch Dis Child Fetal Neonatal Ed 2001;84:F201-F204 ( May )

Review

Hepatitis C in pregnancy

N Hadzic'

Department of Child Health, King's College Hospital, Denmark Hill, London SE5 9RJ, United Kingdom

Correspondence to: Dr Hadzic' nedim.hadzic@kcl.ac.uk

Accepted 4 January 2001

The first 150 words of the full text of this article appear below.

    Introduction

At the end of the second millennium, chronic hepatitis C virus (HCV) infection is recognised as a major public health problem. The global prevalence of chronic HCV infection is estimated to be approaching 3% (over 170 million HCV infected people) with considerable geographical variation, ranging from 0.01-0.1% in the United Kingdom and Scandinavia to 17-26% in Egypt.1 At present, the infection rate peaks among adults aged 30-49 and declines sharply in those older than 50 years, suggesting acquisition of HCV within the past 10-30 years.1 In the United States, the estimated anti-HCV prevalence in 6-11 year old children is 0.2%, and among adolescents aged 12-19 it is 0.4%.2 3 HCV induced end stage chronic liver disease is a leading indication for transplantation in the adult population of the United States.1 2 Anti-HCV screening of blood products introduced during the early 1990s has minimised this mode of HCV acquisition, leaving vertical transmission from infected mothers . . . [Full text of this article]




This article has been cited by other articles:


Home page
GutHome page
S J Hutchinson, D J Goldberg, M King, S O Cameron, L E Shaw, A Brown, J MacKenzie, K Wilson, and L MacDonald
Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis
Gut, April 1, 2004; 53(4): 593 - 598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health